OZETTE - Trademark Details
Status: 748 - Statement Of Use - To Examiner
Serial Number
97977789
Word Mark
OZETTE
Status
748 - Statement Of Use - To Examiner
Status Date
2024-03-22
Filing Date
2022-04-21
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2023-06-27
Attorney Name
Law Office Assigned Location Code
O10
Employee Name
AURAND, MEGAN LEE
Statements
Goods and Services
Providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for analyzing immune data for the purposes of medical research, diagnosis, and treatment; providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for analyzing immune data for the purposes of identifying, prescribing and monitoring medications; providing temporary use of non-downloadable computer software using artificial intelligence (AI) and machine learning for diagnosing, monitoring and treating diseases and disorders, namely, infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders; scientific research and development; pharmaceutical research and development; medical research; medical and pharmaceutical research services; cloud hosting provider services for storing, analyzing and sharing biological information; providing an online network environment service featuring technology that enables users to store, analyze and share data in the fields of life science; technical support services, namely, infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of life science; product design and development of laboratory apparatus and instruments and design and development of computer software systems for use in analysis of biomolecules; installation and maintenance of computer software and software databases used in the field of analysis of biomolecules; consultancy, information, and advisory services in the field of medical research analysis of biomolecules, diseases, disorders, and treatment efficacy; product development, namely, developing equipment for use in preparing, detecting, sequencing, quantifying, and analyzing proteins and other biological molecules, and automated laboratory equipment and systems, and computer systems for collecting, storing, analyzing, and reporting biological information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all the foregoing in the fields of scientific and clinical research; medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants, adjuvant formulations, biologic formulations, drug delivery, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic formulations, and drug delivery; custom design and development of chemical reagents and biochemical assays; testing of pharmaceuticals; scientific laboratory services; computer and scientific research in the field of artificial intelligence (AI) and machine learning for analysis of immune data, disease states, and treatment response
Goods and Services
Medical testing and reporting for diagnostic or treatment purposes; consultancy, information, and advisory services in the field of medical treatment of infectious disease, cancer, autoimmune disorders, cardiovascular disease, and neurological disorders
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2022-04-27
Primary Code
042
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2022-04-27
Primary Code
044
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Chelsea E. Carbone
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Continuity Parent | 97374157 |
Trademark Events
Event Date | Event Description |
2022-04-25 | NEW APPLICATION ENTERED |
2022-04-27 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
2023-02-08 | ASSIGNED TO EXAMINER |
2023-02-23 | NON-FINAL ACTION WRITTEN |
2023-02-23 | NON-FINAL ACTION E-MAILED |
2023-02-23 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2023-05-22 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2023-05-22 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2023-05-24 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2023-05-25 | EXAMINERS AMENDMENT -WRITTEN |
2023-05-25 | EXAMINERS AMENDMENT E-MAILED |
2023-05-25 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
2023-05-25 | EXAMINER'S AMENDMENT ENTERED |
2023-05-25 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2023-06-07 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2023-06-27 | PUBLISHED FOR OPPOSITION |
2023-06-27 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2023-08-22 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
2024-02-05 | SOU TEAS EXTENSION RECEIVED |
2024-02-06 | TEAS STATEMENT OF USE RECEIVED |
2024-02-29 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
2024-02-06 | TEAS REQUEST TO DIVIDE RECEIVED |
2024-02-05 | SOU EXTENSION 1 FILED |
2024-03-22 | SOU EXTENSION 1 GRANTED |
2024-02-06 | DIVISIONAL REQUEST RECEIVED |
2024-03-22 | DIVISIONAL PROCESSING COMPLETE |
2024-02-06 | USE AMENDMENT FILED |
2024-03-22 | STATEMENT OF USE PROCESSING COMPLETE |